Press release
Investigation announced for Long-Term Investors in shares of Novavax, Inc. (NASDAQ: NVAX)
An investigation on behalf of current long term investors in Novavax, Inc. (NASDAQ: NVAX) shares.
Investors who are current long term investors in Novavax, Inc. (NASDAQ: NVAX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: NVAX stocks follows a lawsuit filed against Novavax, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: NVAX stocks, concerns whether certain Novavax directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the District of Maryland the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that: (i) Novavax overstated its manufacturing capabilities and downplayed manufacturing issues that would impact its approval timeline for NVX-CoV2373; (ii) as a result, Novavax was unlikely to meet its anticipated EUA regulatory timelines for NVX-CoV2373; (iii) accordingly, the Company overstated the regulatory and commercial prospects for NVX-CoV2373; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Novavax, Inc. (NASDAQ: NVAX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Novavax, Inc. (NASDAQ: NVAX) here
News-ID: 2573291 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Novavax
Vaccine Adjuvants Market Next Big Thing | Major Giants- GlaxoSmithKline, Novavax …
Archive Market Research published a new research publication on "Vaccine Adjuvants Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Vaccine Adjuvants market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Coronavirus Market to See Major Growth by 2026 | Moderna,Novavax
The Latest Released Coronavirus market study has evaluated the future growth potential of Global Coronavirus market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Vaccines Delivery Market Worth Observing Growth: Key Players BioCSL, Novavax, Va …
A new business intelligence report released by HTF MI with title "Global Vaccines Delivery Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application" is designed covering micro level of analysis by manufacturers and key business segments. The Global Vaccines Delivery Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and…
Coronavirus Vaccine Investment Market Still Going Strong | AbbVie, Novavax, Pfiz …
The coronavirus (COVID-19) disease is affecting 210 countries and territories around the world and 2 international conveyances. The major players are investing in the research and development activities of the coronavirus vaccine. In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success. They are ensuring quick development of new…
Whats driving the Coronavirus Vaccine Market Demand? Pfizer Inc.,, Johnson & Joh …
A detailed study on 'Coronavirus Vaccine Market' formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in the…
Global Virus Like Particles Market 2018-2025 GlaxoSmithKline, Merck, Novavax, Ta …
Market study on Global Virus Like Particles Market 2018 Research Report presents a professional and complete analysis of Global Virus Like Particles Market on the current market situation.
Report provides a general overview of the Virus Like Particles industry 2018 including definitions, classifications, Virus Like Particles market analysis, a wide range of applications and Virus Like Particles industry chain structure. The 2018's report on Virus Like Particles industry offers…
